Download Files:
Products Details
Product Description
– HCV-IN-41 (compound 4) is a highly potent hepatitis C virus (HCV) inhibitor with an EC50 value of 0.006762 nM, 5.183 nM, 1.365 nM and 142.2 nM for HCV genotype 1b, 2a, 3a and 4a, respectively. HCV-IN-41 reduces HCV RNA replication[1].
Web ID
– HY-147885
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C48H56N6O8
References
– [1]Abdel Karim SE, et al. Symmetric benzidine derivatives as anti-HCV agents: Insight into the nature, stereochemistry of the capping amino acid and the size of the terminal capping carbamates. Bioorg Chem. 2020 Sep;102:104089.
CAS Number
– 2468169-71-1
Molecular Weight
– 844.99
SMILES
– CC(COC(N[C@H](C1=CC=CC=C1)C(N2CCC[C@H]2C(NC3=CC=C(C=C3)C4=CC=C(C=C4)NC([C@@H]5CCCN5C([C@@H](C6=CC=CC=C6)NC(OCC(C)C)=O)=O)=O)=O)=O)=O)C
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– HCV
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
